These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9350956)

  • 21. Dynamics of neurological soft signs and its relationship to clinical course in patients with first-episode schizophrenia.
    Prikryl R; Ceskova E; Tronerova S; Kasparek T; Kucerova HP; Ustohal L; Venclikova S; Vrzalova M
    Psychiatry Res; 2012 Dec; 200(2-3):67-72. PubMed ID: 22494706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neurological soft signs in schizophrenic patients and their nonaffected siblings].
    Mechri A; Slama H; Bourdel MC; Chebel S; Mandhouj O; Krebs MO; Gaha L
    Encephale; 2008 Oct; 34(5):483-9. PubMed ID: 19068337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Symptom dimensions in old-age schizophrenics. Relationship to neuropsychological and motor abnormalities.
    Sauer H; Hornstein C; Richter P; Mortimer A; Hirsch SR
    Schizophr Res; 1999 Aug; 39(1):31-8. PubMed ID: 10480665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychomotor disturbances in psychiatric patients as a possible basis for new attempts at differential diagnosis and therapy. Part VI. Evaluation of psychomotor training programs in schizophrenic patients.
    Günther W; Streck P; Müller N; Mair GR; Kalischek E; Bender W; Günther R
    Eur Arch Psychiatry Clin Neurosci; 1995; 245(6):288-98. PubMed ID: 8527465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurological soft signs in early stage of schizophrenia associated with obsessive-compulsive disorder.
    Focseneanu BE; Dobrescu I; Marian G; Rusanu V
    J Med Life; 2015; 8 Spec Issue(Spec Issue):74-81. PubMed ID: 26361516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurological soft signs (NSS) in 200 treatment-naïve cases with schizophrenia: a community-based study in a rural setting.
    Shibre T; Kebede D; Alem A; Kebreab S; Melaku Z; Deyassa N; Negash A; Fekadu A; Fekadu D; Medhin G; Negeri C; Jacobsson L; Kullgren G
    Nord J Psychiatry; 2002; 56(6):425-31. PubMed ID: 12495537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EEG coherence and syndromes in schizophrenia.
    Norman RM; Malla AK; Williamson PC; Morrison-Stewart SL; Helmes E; Cortese L
    Br J Psychiatry; 1997 May; 170():411-5. PubMed ID: 9307688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurological abnormalities in first-episode schizophrenia: temporal stability and clinical and outcome correlates.
    Emsley R; Turner HJ; Oosthuizen PP; Carr J
    Schizophr Res; 2005 Jun; 75(1):35-44. PubMed ID: 15820322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive inhibition and schizophrenic symptom subgroups.
    Williams LM
    Schizophr Bull; 1996; 22(1):139-51. PubMed ID: 8685656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Childhood behavioral precursors of adult symptom dimensions in schizophrenia.
    Baum KM; Walker EF
    Schizophr Res; 1995 Aug; 16(2):111-20. PubMed ID: 7577764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurological soft signs and their relationship to 1-year outcome in first-episode schizophrenia.
    Prikryl R; Ceskova E; Kasparek T; Kucerova H
    Eur Psychiatry; 2007 Nov; 22(8):499-504. PubMed ID: 17614262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Soft signs and neuropsychological performance in schizophrenia.
    Flashman LA; Flaum M; Gupta S; Andreasen NC
    Am J Psychiatry; 1996 Apr; 153(4):526-32. PubMed ID: 8599401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurocognitive deficits and neurological signs in schizophrenia.
    Wong AH; Voruganti LN; Heslegrave RJ; Awad AG
    Schizophr Res; 1997 Feb; 23(2):139-46. PubMed ID: 9061810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Three-dimensional ultrasonic movement analysis of gait and hand-movements in schizophrenic patients].
    Putzhammer A; Perfahl M; Pfeiff L; Müller JL
    Psychiatr Prax; 2005 Apr; 32 Suppl 1():S38-42. PubMed ID: 15818519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does sex influence the relation between symptoms and neurocognitive functions in schizophrenia?
    Malla AK; Norman RM; Morrison-Stewart S; Williamson PC; Helmes E; Cortese L
    J Psychiatry Neurosci; 2001 Jan; 26(1):49-54. PubMed ID: 11212594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The five symptom dimensions and depression in schizophrenia.
    Lee KH; Harris AW; Loughland CM; Williams LM
    Psychopathology; 2003; 36(5):226-33. PubMed ID: 14571051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal neurological signs at the onset of psychosis.
    Scheffer RE
    Schizophr Res; 2004 Sep; 70(1):19-26. PubMed ID: 15246459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Syndromes of schizophrenia and smooth-pursuit eye movement dysfunction.
    Lee KH; Williams LM; Loughland CM; Davidson DJ; Gordon E
    Psychiatry Res; 2001 Feb; 101(1):11-21. PubMed ID: 11223115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurodevelopmental indices and the development of psychotic symptoms in subjects at high risk of schizophrenia.
    Lawrie SM; Byrne M; Miller P; Hodges A; Clafferty RA; Cunningham Owens DG; Johnstone EC
    Br J Psychiatry; 2001 Jun; 178():524-30. PubMed ID: 11388968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Psychomotor symptoms in schizophrenia: the importance of a forgotten syndrome].
    Morrens M; Hulstijn W; Sabbe BG
    Tijdschr Psychiatr; 2008; 50(11):713-24. PubMed ID: 18991232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.